XOMA Royalty (XOMA) Prepaid Assets (2010 - 2026)
XOMA Royalty's (XOMA) quarterly Prepaid Assets came in at $473000.0 in Q1 2026, down 51.29% year-on-year from $971000.0 in Q1 2025, and down 44.48% quarter-over-quarter from $852000.0 in Q4 2025.
XOMA Royalty (XOMA) Prepaid Assets (2010 - 2026) Analysis & Trends
XOMA Royalty has disclosed Prepaid Assets across 17 years of filings, most recently posting $473000.0 for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $473000.0, down 51.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $473000.0 (down 51.29% YoY), and the FY2025 annual result was $852000.0, down 58.96% from the prior year.
- Prepaid Assets came in at $473000.0 for Q1 2026 at XOMA Royalty, down from $852000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $2.8 million in Q2 2024 to a low of $270000.0 in Q1 2024.
- The 5-year median for Prepaid Assets is $799000.0 (2023), against an average of $1.0 million.
- Across the five-year window, Prepaid Assets surged 329.81% in 2024 and slumped 82.02% in 2025, its largest moves.
- XOMA Royalty's Prepaid Assets stood at $725000.0 in 2022, then plunged by 33.38% to $483000.0 in 2023, then jumped by 329.81% to $2.1 million in 2024, then plunged by 58.96% to $852000.0 in 2025, then tumbled by 44.48% to $473000.0 in 2026.
- The last three Prepaid Assets figures came in at $473000.0 (Q1 2026), $852000.0 (Q4 2025), and $967000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | XOMA Royalty | 5.49 Mn | -60.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 473,000.00 |
| Dec 31, 2025 | 852,000.00 |
| Sep 30, 2025 | 967,000.00 |
| Jun 30, 2025 | 507,000.00 |
| Mar 31, 2025 | 971,000.00 |
| Dec 31, 2024 | 2.08 Mn |
| Sep 30, 2024 | 2.38 Mn |
| Jun 30, 2024 | 2.82 Mn |
| Mar 31, 2024 | 270,000.00 |
| Dec 31, 2023 | 483,000.00 |
| Sep 30, 2023 | 776,000.00 |
| Jun 30, 2023 | 799,000.00 |
| Mar 31, 2023 | 456,000.00 |
| Dec 31, 2022 | 725,000.00 |
| Sep 30, 2022 | 997,000.00 |
| Jun 30, 2022 | 1.05 Mn |
| Mar 31, 2022 | 409,000.00 |
| Dec 31, 2021 | 613,000.00 |
| Sep 30, 2021 | 969,000.00 |
| Jun 30, 2021 | 1.14 Mn |